Beth E. Roxland
Beth E. Roxland, J.D., M.Bioethics is a Senior Consultant on Law, Health Policy and Ethics to law firms, life science and medical institutions, and professional and patient associations. She is also affiliated with a number of academic and research entities, and is a frequent author and public speaker.
Ms. Roxland previously served as Johnson & Johnson’s Bioethics and Strategy Leader, in the Office of the Chief Medical Officer. In this role, Ms. Roxland re-launched and chaired J&J’s Ethics Committee, created an enterprise-wide consultation service for teams and individuals confronting complex research ethics issues, and provided guidance on issues such as post-trial access for former research participants, conducting clinical trials in war-torn regions, testing of a potential Ebola vaccine during a public health crisis, commercialization of stem cell therapies, subject recruitment and withdrawal, and expanded access/ compassionate use.
Prior to joining J&J, Ms. Roxland was the Executive Director of the New York State Task Force on Life and the Law, where she led formulation of policy recommendations for conductingresearch with adults who lack consent capacity, revision of NYS’s Brain Death guidelines, proxy consent for health care decisions, and allocating scarce ventilators during a pandemic.
Ms. Roxland concurrently served as the Special Advisor to the Commissioner of Health on Stem Cell Research Ethics, where she spearheaded creation of state-wide rules on embryonic stem cell protocols, human-animal chimera research, compensation of women who donate their oocytes to stem cell research, informed consent processes, re-contact for return of research results and incidental findings, and downstream uses of biological samples.
Prior to joining the government, Ms. Roxland was a Senior Associate in the litigation department of Simpson Thacher and Bartlett LLP, and a Federal Law Clerk in the Southern District of New York. She graduated from Columbia University with a Bachelor’s degree in Biology, and received a joint J.D. – Master’s in Bioethics Magna Cum Laude from the University of Pennsylvania.